Bellerophon Therapeutics plunges on delisting notice from Nasdaq

Bellerophon Therapeutics

25/07/2023 13:40

** Shares of drug developer Bellerophon Therapeutics slide
35% to 46 cents premarket 
    ** Co says it received delisting notice from Nasdaq on July
19, according to SEC filing 
    ** Co to be delisted from the exchange at the open on July
28 unless it requests a hearing before Nasdaq Hearings Panel to
meet listing rules 
    ** BLPH plans to request a hearing before the panel; stock
will remain listed on Nasdaq till conclusion of the hearing
process 
    ** BLPH second worst performer in premarket trading across
exchanges 
    ** Up to Monday's close, BLPH shares down 21.3% YTD

 (Reporting by Shreyashi Sanyal)
 ((Shreyashi.Sanyal@thomsonreuters.com;))